Caitlin Rother finished the book in a frenzy of rewriting after obtaining — she won't say how — a "treasure trove of research." ...

Eyecyte-RPE phase 1 study showed promising safety and efficacy, with no serious adverse events and significant vision ...

The summer transfer window is now open through to September and this week should see the biggest deal of the year finally ...